Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals. Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
KEY PEOPLE

Dr Miri Halperin Wernli, Group CEO, Co-Founder and Executive Director
Dr Miri Halperin Wernli has over 25 years of strategic and operational leadership in global drug and product development in the pharmaceutical and biomedical industries. She held worldwide executive leadership positions in R&D and in strategic marketing within global pharmaceutical companies in Switzerland and in the US.

Boaz Wachtel, Non-Executive Chairman and Co-Founder
Boaz Wachtel is a leading medical cannabis expert, co-founder and former managing director of Phytotech Medical (MMJ.ASX), Australia’s first publicly traded medical cannabis company. He initiated and helped implement the National Medical Cannabis Program in Israel.

John Griese, Chief Operating Officer
John Griese is an expert in cannabis and food manufacturing and supply chain. John has 30 years experience in executive operations roles with Pepsi and Nestle and more recently developed Cannabis experience as COO of Bloom Farms a large branded manufacturer and distributor in the California regulated market.
RELATED STOCKHEAD STORIES
Health & Biotech
Creso Pharma books another cannaQIX order in South Africa, as cash stockpile soars
Health & Biotech
Creso Pharma shares spike as Democrats win improves prospects for US cannabis legalisation
News
Winners Column: Here are the top 50 ASX small cap stocks for December
Health & Biotech
Check Up: Joining ‘observational study’ sends Avecho shares soaring
Health & Biotech
Creso Pharma receives first pet-health cannabis orders in Latin America
Health & Biotech
Creso Pharma’s CBD medicines will be available prescription free in Australia
News
Weekly ASX small cap wrap: Who are the cup winners and wooden spoon recipients?
Experts
ScoPo’s health powerplays: ‘Cannabis stocks went on a ride’
Health & Biotech
Creso Pharma signs deal with natural lifestyle brand supplier Martin & Pleasance
News
10 at 10: These ASX stocks have surprised their shareholders this morning
Health & Biotech
Weed Week: Cannabis is back with a bang as stars finally begin to align
News
Cannabis stocks take a well-earned breather after days of strong gains
News
Check Up: Creso Pharma gets really, really high; leads ASX health sector
Health & Biotech
Creso Pharma subsidiary expands into Canada’s biggest recreational market
News
ASX Small Cap Lunch Wrap: Who’s getting jabbed today?
News
10 at 10: These ASX stocks are liquid hot this morning
Health & Biotech